Owner Novartis AG

Inventors Yoon, Taeyoung; Miranda, Karl; Jewell Jr., Charles Francis; Soldermann, Nicolas; Dipietro, Lucian; Monovich, Lauren G.; Zhu, Qingming; Meredith, Erik; Burgis, Robin; Rao, Chang; Capparelli, Michael Paul; Gamber, Gabriel G.

Agent Davies Collison Cave

Pub. Number AU-A-2009256574

PCT Pub. Number WO2009/150230

Priority 61/061,384 13.06.08 US

Filing date 12 June 2009

Wipo publication date 17 December 2009

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or